Recent ARWR Stock Price | ARWR Stock Predictions | |
$19.95 | ![]() +137.74% |
$47.43 |
Recent ARWR Analyst Ratings Breakdown, Making ARWR Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 9 | 9 | 9 | 9 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 5 | 5 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.73 | 1.73 | 1.73 | 1.73 |
For the ARWR stock predictions from the analysts covering Arrowhead Pharmaceuticals Inc, we have collected all of the individual ARWR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 14 different analysts covering ARWR (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ARWR stock predictions may vary widely, another useful metric to consider is the median ARWR stock prediction, which represents the price at which half of the analysts
made ARWR stock predictions that were higher and half made ARWR stock predictions that were lower. This makes for a different take on the ARWR stock predictions out there, as compared to average or mean.
And that median across all the individual ARWR stock predictions was: $43.5 as of 2025-02-18.
The very highest of the ARWR stock predictions for one year price target was $80.0, while the very lowest of the ARWR stock predictions in the analyst group was
$24.0 (with a standard deviation of $19.743). Get the latest Zacks research report on ARWR — FREE
Find out: ARWR next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ENTA Stock Predictions
RMAX Stock Predictions
EQIX Stock Predictions
RAD Stock Predictions
PGC Stock Predictions
SCHN Stock Predictions
OTTR Stock Predictions
PKX Stock Predictions
FLIC Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Buy (3.27 out of 4) 45th percentile
(ranked lower than approx. 55% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |